Aceragen Inc (FRA:V9Z) Stock News, Headlines & Updates
Aceragen Inc Stock News from GuruFocus
- 1
- 2
Aug 04, 2023
Aceragen, Inc. to Delist from The Nasdaq Stock Market
Marketwired • 4:00pm
Feb 06, 2023
Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study
Stock market mentor • 9:00am
Jun 26, 2022
Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC
GuruFocusNews • 8:09am
May 17, 2022
Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC
GuruFocusNews • 7:06am
May 05, 2022
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
GuruFocusNews • 4:02pm
May 18, 2021
Idera Pharmaceuticals Announces Corporate Updates
Marketwired • 4:01pm
Mar 02, 2021
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Marketwired • 7:02pm
Jan 11, 2021
Idera Pharmaceuticals to Present at Upcoming Conferences
Marketwired • 7:01am
Dec 15, 2020
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20.7 Million
Marketwired • 11:01am
Nov 18, 2020
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
Marketwired • 7:01pm
Oct 30, 2020
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
Marketwired • 7:02pm
Sep 28, 2020
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
Marketwired • 11:00am
Sep 15, 2020
Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020
Marketwired • 7:00am
Aug 05, 2020
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
Marketwired • 7:01pm
Jul 15, 2020
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
Marketwired • 11:00am
Jun 02, 2020
Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment of Micro-Satellite Stable Colorectal Cancer
Marketwired • 11:02am
May 01, 2020
Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of Stockholders
Marketwired • 7:00am
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
Marketwired • 7:01pm
Apr 23, 2020
Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020
Marketwired • 7:01am
Apr 21, 2020
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
Marketwired • 7:00am
Apr 08, 2020
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
Marketwired • 7:00pm
Mar 12, 2020
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Marketwired • 7:00am
Mar 05, 2020
Idera Pharmaceuticals Completes Enrollment in ILLUMINATE-301, its Registrational Trial of Tilsotolimod in Combination with Ipilimumab in Patients with Anti-PD-1 Refractory Advanced Melanoma
Marketwired • 7:00am
Jan 14, 2020
Idera Pharmaceuticals Provides 2020 Update and Outlook
Marketwired • 7:00am
Dec 23, 2019
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
Marketwired • 11:00am
Nov 07, 2019
Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results
Marketwired • 7:00pm
Oct 21, 2019
Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037
Marketwired • 7:00am
Sep 30, 2019
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors
Marketwired • 7:00am
Sep 04, 2019
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
Marketwired • 7:00am
Aug 30, 2019
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference
Marketwired • 11:00am
Aug 08, 2019
Idera Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2019 Financial Results
Marketwired • 11:03am
Aug 07, 2019
Idera to Release 2019 Second Quarter Results on August 8, 2019
Marketwired • 7:01pm
Jul 23, 2019
Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer
Marketwired • 7:03am
Jun 19, 2019
Idera Pharmaceuticals to Present at the 2019 JMP Securities Life Sciences Conference
Marketwired • 7:01pm
May 03, 2019
Idera Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
Marketwired • 7:01pm
Apr 10, 2019
Idera Pharmaceuticals Provides Corporate Update
Marketwired • 7:00am
Apr 02, 2019
Mar 07, 2019
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
Marketwired • 7:02pm
Feb 27, 2019
Jan 04, 2019
Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
Marketwired • 7:01am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers